Hepcidin level predicts hemoglobin concentration in individuals undergoing repeated phlebotomy

Haematologica

Volumn 98, Issue 8, 2013, Pages 1324-1330

  Mast, Alan E ^a,b   Schlumpf, Karen S ^c   Wright, David J ^c   Johnson, Bryce ^c   Glynn, Simone A ^d   Busch, Michael P ^e   Olbina, Gordana ^f   Westerman, Mark ^f   Nemeth, Elizabeta ^g   Ganz, Tomas ^g  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c WESTAT   (United States)

^d National Heart Lung and Blood Institute   (United States)

^e BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^f Intrinsic LifeSciences LLC   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN; HEPCIDIN;

ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIESIS; FEMALE; GENDER; GENOTYPE; HUMAN; IRON INTAKE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENSTRUATION; MULTICENTER STUDY (TOPIC); PHLEBOTOMY; RACE; SMOKING;

ADOLESCENT; ADULT; BLOOD DONORS; FEMALE; HEMOGLOBINS; HEPCIDINS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHLEBOTOMY; PREDICTIVE VALUE OF TESTS; TIME FACTORS; YOUNG ADULT;

EID: 84881006013     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2012.070979     Document Type: Article

References (22)

1. Finch C. Regulators of iron balance in humans. Blood. 1994;84(6):1697-702.
2. Weinberg ED. Iron availability and infection. Biochim Biophys Acta. 2009;1790(7): 600-5.
3. Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta. 2012; 1823(9):1434-43.
4. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, et al. From the cover: lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. PNAS. 2001;98(15):8780-5.
5. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090-3.
6. Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human serum hepcidin. Blood. 2008;112(10):4292-7.
7. Preza GC, Ruchala P, Pinon R, Ramos E, Qiao B, Peralta MA, et al. Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. J Clin Invest. 2011;121(12):4880-8.
8. Ramos E, Ruchala P, Goodnough JB, Kautz L, Preza GC, Nemeth E, et al. Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis. Blood. 2012;120(18):3829-36.
9. Cable RG, Glynn SA, Kiss JE, Mast AE, Steele WR, Murphy EL, et al. Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion. 2011; 51(3):511-22.
10. Cable RG, Glynn SA, Kiss JE, Mast AE, Steele WR, Murphy EL, et al. Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion. 2012;52(4):702-11.
11. Finch CA, Cook JD, Labbe RF, Culala M. Effect of blood donation on iron stores as evaluated by serum ferritin. Blood. 1977;50(3):441-7.
12. Simon TL, Garry PJ, Hooper EM. Iron stores in blood donors. JAMA. 1981;245(20):2038-43.
13. Mast AE, Schlumpf KS, Wright DJ, Custer B, Spencer B, Murphy EL, et al. Demographic correlates of low hemoglobin deferral among prospective whole blood donors. Transfusion. 2010;50(8):1794-802.
14. Mast AE, Lee TH, Schlumpf KS, Wright DJ, Johnson B, Carrick DM, et al. The impact of HFE mutations on haemoglobin and iron status in individuals experiencing repeated iron loss through blood donation. Br J Haematol. 2012;156(3):388-401.
15. Bothwell TH, Pirzio-Biroli G, Finch CA. Iron absorption. I. Factors influencing absorption. J Lab Clin Med. 1958;51(1):24-36.
16. Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med. 2005;353(11):1135-46.
17. Papanikolaou G, Tzilianos M, Christakis JI, Bogdanos D, Tsimirika K, MacFarlane J, et al. Hepcidin in iron overload disorders. Blood. 2005;105(10):4103-5.
18. Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S. Suppression of hepcidin during anemia requires erythropoietic activity. Blood. 2006;108(12):3730-5.
19. Vokurka M, Krijt J, Sulc K, Necas E. Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol Res. 2006;55(6):667-74.
20. Prentice AM, Doherty CP, Abrams SA, Cox SE, Atkinson SH, Verhoef H, et al. Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children. Blood. 2012;119(8):1922-8.
21. Radtke H, Meyer T, Kalus U, Rocker L, Salama A, Kiesewetter H, et al. Rapid identification of iron deficiency in blood donors with red cell indexes provided by Advia 120. Transfusion. 2005;45(1):5-10.
22. Semmelrock MJ, Raggam RB, Amrein K, Avian A, Schallmoser K, Lanzer G, et al. Reticulocyte hemoglobin content allows early and reliable detection of functional iron deficiency in blood donors. Clin Chim Acta. 2012;413(7-8):678-82.